The Latest Breaking News from Joe Kiani

With medical errors still claiming hundreds of thousands of lives annually, Joe Kiani's Patient Safety Movement Foundation is pushing for bold, systemic change to put patient safety at the core of modern medicine.

Masimo stock jumped Wednesday after Chief Executive Joe Kiani resigned. But, importantly, the company's other executives stayed on board.

Apple is seeking to end the pause on its wearable, but new opposition from the ITC could be the final nail in the coffin.

Joe Kiani, Masimo CEO, was recently interviewed on his legal battle with Apple, disputing their Blood Oxygen technology.

Apple's decision to withdraw the Apple Watch Series 9 and Ultra 2 from sale could cost it $400 million this holiday season.

The CEO of Masimo, the company that owns a patent Apple is accused of infringing, says he'd be willing to discuss a settlement — but Apple seems uninterested.

LAS VEGAS — Robert Banghart’s life was saved by naloxone twice in one evening when he overdosed from heroin.

Experts say it's not a sign of an ESG backlash.

Masimo Corp's (NASDAQ:MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700 in Q1 of 2022. The adjusted operating margin remained unchanged at 22.9%. The company reported…